Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Pneumonia
- Pharmacology and Therapeutics
- Hepatitis
- Physiology
- Chronic Disease
- Internal Medicine
- Molecular Biology
- Cancer Clinic
Abstract
Citation: Clin Case Rep Int. 2022;6(1):1292.DOI: 10.25107/2638-4558.1292
Prostatic Carcinosarcoma: A Case Report and Review of Literature
Vanessa Andrade*
Urology Service, Centro Hospitalar Lisboa Central, Portugal
*Correspondance to: Vanessa Andrade
PDF Full Text Case Report | Open Access
Abstract:
Introduction: Prostatic carcinosarcomas are extremely rare, representing less than 0.1% of all prostate cancers. Objectives: Clinical report of a case of prostatic carcinosarcoma and review of the literature. Methods and Materials: We report a case from a patient of our centre diagnosed with carcinosarcoma after a Millin prostatectomy. A review of the literature was also performed. Clinical Report: We report a case of a 68 years old patient diagnosed due to a surgery to benign prostatic hyperplasia. He had some infectious complications after that, needing admission to the hospital and specific management. He was treated with chemotherapy and hormonal treatment, initially with some response, but later with progression of disease and worsening of his general status, which became fatal after 13 months after diagnosis. Discussion/Conclusion: Carcinosarcoma is a rare and extremely aggressive entity. Unfortunately, it has a really bad prognosis and, as we seen, became fatal to our patient. Due to the reduced number of cases, it still lacks recommendations regarding the best treatment options. In the majority of patients, surgery, chemotherapy and radiotherapy are valid options.
Keywords:
Prostate cancer; Carcinosarcoma; Pelvic Exenteration; Oncology
Cite the Article:
Andrade V. Prostatic Carcinosarcoma: A Case Report and Review of Literature. Clin Case Rep Int. 2022; 6: 1292.